Details for New Drug Application (NDA): 205977
✉ Email this page to a colleague
The generic ingredient in PITAVASTATIN CALCIUM is pitavastatin calcium. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pitavastatin calcium profile page.
Summary for 205977
Tradename: | PITAVASTATIN CALCIUM |
Applicant: | Hetero Labs Ltd V |
Ingredient: | pitavastatin calcium |
Patents: | 0 |
Pharmacology for NDA: 205977
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Suppliers and Packaging for NDA: 205977
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205977 | ANDA | Camber Pharmaceuticals, Inc. | 31722-875 | 31722-875-90 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-875-90) |
PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205977 | ANDA | Camber Pharmaceuticals, Inc. | 31722-876 | 31722-876-90 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-876-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Apr 30, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Apr 30, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Apr 30, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription